Bio-Rad Laboratories, Inc. Share Price & Technical Analysis
BIO · $287.7 (+0.35%)
Healthcare / Medical Devices
$287.7
+0.35%
Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, pur…
Price chart
Seasonality
May has 3 positive and 2 negative years (last 5 years shown)
10% return in May, -6% avg return in past 3 year May month.
4% return in 2026, -6% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -3% | -4% | 1% | 0% | 10% | – | – | – | – | – | – | – | 4% |
| 25 | 9% | -25% | -9% | 1% | -7% | 7% | 0% | 10% | -5% | 14% | 2% | -6% | -7% |
| 24 | 0% | 2% | 6% | -22% | 6% | -5% | 24% | -1% | 0% | 6% | -6% | -3% | 8% |
| 23 | 9% | 1% | 1% | -5% | -17% | 1% | 7% | -1% | -11% | -23% | 11% | 6% | -20% |
| 22 | -20% | 3% | -10% | -11% | 6% | -9% | 14% | -13% | -13% | -16% | 16% | 0% | -53% |
Monthly return % by calendar month · historical pattern, not a forecast
Neutral · Emerging · Strong
Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantify biological materials, including cells, proteins, and nucleic acids used in research and biopharmaceutical laboratory environments, as well as for biopharmaceutical manufacturing, quality control process, food safety, and science education applications. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology companies, food producers, and testing laboratories. Its Clinical Diagnostics segment designs, manufactures, markets, and supports diagnostic test systems, informatics systems, test kits, and specialized quality controls for clinical, hospital, diagnostic reference, and transfusion and physician office laboratories, as well as software. The company offers its products through its direct commercial organization, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$6.51B
P/E ratio
40.42
52W high
$343.1
52W low
$211.4
Volume
1,64,099
Beta
1.06
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Bio-Rad Laboratories, Inc. share price today?
- Bio-Rad Laboratories, Inc. (BIO) last traded around $287.7 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does BIO have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for BIO. Download the app for real-time alerts.
- How can I analyze Bio-Rad Laboratories, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.